Use of Anti-Parkinsonian Medications among Incident Parkinson Disease Patients (S24.004)
To compare demographic and geographic characteristics of U.S. Medicare beneficiaries newly diagnosed with Parkinson disease (PD) who did or did not fill a prescription for an anti-parkinsonian medication within 12 months of diagnosis.
Authors
- Alejandra Camacho‐Soto (ORCID: https://orcid.org/0000-0001-6314-8553)
- Brittany Krzyzanowski (ORCID: https://orcid.org/0000-0002-4774-6120)
- Brad A. Racette (ORCID: https://orcid.org/0000-0002-9582-8235)
- Jordan Killion (ORCID: https://orcid.org/0000-0003-3155-1107)
- Susan Searles Nielsen (ORCID: https://orcid.org/0000-0001-7768-4736)
- Sai Anmisha Doddamreddy
Institutions
- Barrow Neurological Institute (US)
- Washington University in St. Louis (US)
- University of Kansas Medical Center (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212253
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00